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A B S T R A C T
Background: Varicella zoster virus presents clinically as primary (chickenpox) or secondary (herpes zoster) in-
fection. Cutaneous and extracutaneous dissemination may occur, usually in immunocompromised patients. VZV
hepatitis that progresses to fulminant hepatic failure is very rare and fatal. To the best of our knowledge, 9 cases
have been reported to date, of which 7 were in immunocompromised adults, and only one patient was on short
duration steroid therapy.
Presentation of case: We present a 26-year old man who was admitted initially with acute abdomen as query
persistent biliary colic. Later, he showed clinical and laboratory findings of VZV hepatitis that progressed rapidly
despite maximal medical ICU support and he expired on day 3 of admission.
Conclusions: Acute VZV infection may present as fulminant hepatitis. The presentation may initially be chal-
lenging for the diagnosis and should be considered if the patient has been in contact with a sick case. Low dose
corticosteroid could carry a risk for fatal VZV fulminant hepatitis and should be used very cautiously especially
with VZV patients’ contacts. Further causative relationships remain to be established.
1. Background
Varicella zoster virus presents clinically as primary (chickenpox) or
secondary (herpes zoster) infection. Primary infection typically pro-
duces generalized vesicular rash. The virus then establishes latency in
the dorsal root ganglia and may later reactivate as secondary infection,
generating a localized dermatomal “shingles” vesicular eruption.
Cutaneous and extracutaneous dissemination can occur, mostly in im-
munocompromised individuals [1]. Fulminant acute hepatic failure
(FAHF) due to VZV hepatitis is extremely rare and deadly, with only 9
cases reported in the literature. Seven of these nine cases were im-
munocompromised patients, one was 15 year old child and only one
case was on short term steroid treatment; most of them died of the
disease [2–10]. In this paper, we present, to the best of our knowledge,
the second case of VZV FAHF to develop in a healthy adult on low dose
steroid that unusually presented initially as acute abdomen. We report
this case in line with the updated consensus-based surgical case report
(SCARE) criteria [11].
2. Case presentation
A 26-year old man presented to the emergency department at
Hamad Medical Corporation (HMC) in Doha, Qatar, with a three-day
history of severe colicy epigastric and right upper quadrant abdominal
pain, radiating to the back, associated with two episodes of vomiting
and constipation. This was his first time to have such pain. He had past
surgical history of open appendectomy during adolescence and was
currently on oral medications for sciatica (prednisolone 5 mg BID for
one-week, Naproxen 225 mg BID and Gabapentin 300 mg daily).
Otherwise, he had no comorbidities, and the other systemic review was
unremarkable. No recent travel or interaction with sick contacts was
mentioned at the initial encounter at the emergency department.
The patient had normal vital signs. Abdominal examination re-
vealed severe epigastric and right upper abdomen tenderness.
Otherwise his examination was unremarkable at that time. Initial labs
including CBC, complete metabolic panel were within normal range.
Imaging including abdomen and chest x-rays, and CT angiogram
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abdomen were normal; however, US abdomen showed gallbladder
sludge but with no signs of cholecystitis. Hence the patient was ad-
mitted by the surgical team with an initial diagnosis of possible per-
sistent biliary colic.
During the night of admission day (day 0), the patient was still
having severe colicy pain that required high doses of opioids, para-
cetamol and NSAIDs. Repeat set of all labs were undertaken and due to
the colicy nature and persistent severe pain, a CT with oral contrast was
done to exclude proximal bowel obstruction that might not have shown
on the previous CT with IV contrast. The CT was normal, and the labs
showed slightly rising transaminases (AST 94 IU, ALT 95 IU). The pa-
tient was kept nil per oral, on pain medications with IV hydration and a
repeat set of labs were ordered to be done in 8 hours (early morning of
day 1). During that time, the patient started to develop, for the first
time, a few vesicles on the chest wall, his liver enzymes were rising
(AST 375 IU, ALT 263 IU), and other labs were normal. When ques-
tioned specifically about having contact with someone with similar
vesicular rash, the patient reported that one of his roommates had such
eruption one week ago and did not seek medical advice as it improved
on its own. The patient also did not remember having chickenpox
during his childhood.
The diagnosis of VZV hepatitis was immediately considered and the
medical team was involved. Full hepatitis work up was undertaken on
this admission day 1 during which the patient was still having severe
pain, the rash progressed, and liver enzymes were rapidly rising. Viral
panel came out to be positive for VZV PCR, but other (metabolic, tox-
icology, viral) work ups for hepatitis were negative. Thus, acyclovir was
started by the infectious disease team. On day 2, the patient was shifted
to the ICU as he was developing confusion, high INR, DIC and multi-
organ failure that progressed rapidly despite all supportive measures.
The patient died on day 3. Fig. 1 illustrates the sequence of events.
3. Discussion
VZV can affect both immunosuppressed and immunocompetent
adults [6]. Dissemination of VZV infection and fulminant hepatitis
happens in immunocompromised patients [2–9]; but the infection may
occasionally occur in immunocompetent patients due to extremely
virulent strains that can be rapidly fatal [6]. The role of previous steroid
treatment as a trigger for a temporary immunodepressed state must be
considered [6]. Contrary to most cases reported in the literature, our
patient was a healthy adult who was only on low dose oral steroid for
his back pain. Steroids as a possible risk for disseminated VZV infection
has been reported only in one case. In Italy, a patient on low dose
steroid (prednisolone 5 mg BID for 3 days then 5 mg daily for another 3
days) for tonsillitis developed VZV FAHF [6]. The only difference be-
tween our case and the case in Italy was that their patient had positive
HHSV6 in concomitance with his VZV infection, and it is not clear
whether such coexistent infection could have added to the burden of
the VZV infection driving it into a systemic disease involvement [6].
In terms of presentation, our patient initially presented with ex-
cruciating right upper quadrant pain and tenderness, without the ty-
pical vesicular rash of primary varicella infection which appeared later
on day 1. This is in agreement with a case series (4 patients) where the
initial severe abdominal pain appeared 2–4 days before the classical
herpetic vesicular skin lesions (3 patients), while the fourth case never
developed skin lesions [12]. Visceral VZV may present with abdominal
pain with or without skin eruption [13], where the absence of skin
lesions may delay timely diagnosis and treatment, particularly that
abdominal imaging findings suggestive of the diagnosis of visceral VZV
have rarely been reported [14].
In terms of diagnosis, we had a delay of one day due to the absence
of typical rash and the initial normal liver function tests. Whilst such
delay is consistent with other reports where the initial normal labs
despite pain delayed identification of the disease [4], other cases had
high liver enzymes at the first examination, but delays were still en-
countered due to the absence of rash [3]. Our patient started to show
FAHF on Day 1. The differential diagnosis of FAHF includes venous
obstruction, ischemia, toxins, medications, autoimmune hepatitis, me-
tabolic and infectious causes (primarily viruses, e.g. hepatitis A-E, VZV,
CMV, EBV, HSV, and adenovirus), with VZV being the rarest [10]. Our
patient's history and clinical findings did not suggest ischemic hepatitis,
and he did not have history of exposure to toxins or alcohol ingestion. A
key clue was his contact history with a roommate with similar rash
Fig. 1. Sequence of events across 4 days.
A. Toffaha, et al. Annals of Medicine and Surgery 48 (2019) 115–117
116
(probably chickenpox); had such information been evident earlier, it
would have provided better direction towards the diagnosis.
Definitive diagnosis of VZV hepatitis can be made by liver biopsy,
histopathology, culture, or VZV PCR [10]. Testing for VZV IgG might
differentiate primary infection (negative IgG) from secondary re-
activation (positive IgG) [4]. However, the lack of specificity and sen-
sitivity of the VZV IgM antibodies render the test not very useful
clinically in the differentiation of primary from recurrent VZV infection
nor in the diagnosis [4]. PCR is the only readily available and sensitive
(> 99%) diagnostic tool, and should be used early in any suspicious
case [4]. Our patient had negative VZV antibodies, but positive PCR
confirmed the infection. Liver biopsy in the early stages is questionable,
the disease may exhibit major or minor hepatic impairment but
sometimes an etiologic diagnosis can be obtained by presence of nu-
clear inclusions [15]. Biopsy was not done in our case as PCR confirmed
the diagnosis and post-mortem pathology was declined by the family.
In terms of treatment, the diagnosis of visceral VZV infection is
often difficult due to atypical presentation, so treatment is often de-
layed [10]. Prompt empirical therapy with acyclovir and VZV im-
munoglobulin while awaiting PCR results is warranted if clinically
suspected [16]. Other therapies include VZV immunoglobulin, liver
transplant, IVIG, and supportive care [2–9]. Since VZV AFHF has high
mortality, VZV hepatitis should be considered in all patients with liver
failure who present with rash and early treatment is critical. The timing
of initiation of therapy is widely variable (range: first day of symptoms
to> 1 week) [10], and in some cases diagnosis was even post mortem
and treatment was never initiated [10]. For our patient, the absence of
initial diagnosis upon admission resulted in a one-day delay of acyclovir
treatment; IVIG was started later on Day 2.
As for the outcomes, AFHF is very rare and deadly. Among 8 adult
cases of VZV AFHF, only two survived [10]. Further studies on the rapid
initial treatment of VZV AFHF and its outcome are required.
4. Conclusions
Acute VZV infection may present as AFHF, and the diagnosis may be
challenging based on the initial presentation. Hence detailed contact
history should be taken, and VZV should be considered when a patient
has contact history with someone having VZV active infection. Low
dose corticosteroid may carry a risk for VZV to progress to AFHF.
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